학술논문
Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial
Document Type
Article
Author
Source
In Leukemia Research March 2017 54:73-77
Subject
Language
ISSN
0145-2126